[Graves' orbitopathy: diagnosis, epidemiology and treatments]

A Yan Lun; M Le Bras; E Scharbarg; P Morcel; S Hadjadj; P Lebranchu; D Drui

doi:10.1016/j.revmed.2022.01.006

[Graves' orbitopathy: diagnosis, epidemiology and treatments]

Rev Med Interne. 2022 Apr;43(4):242-251. doi: 10.1016/j.revmed.2022.01.006. Epub 2022 Feb 25.

[Article in French]

Authors

A Yan Lun¹, M Le Bras¹, E Scharbarg¹, P Morcel¹, S Hadjadj¹, P Lebranchu², D Drui³

Affiliations

¹ Service d'endocrinologie diabétologie nutrition, L'institut du thorax, CHU Nantes, Nantes, France.
² Service d'Ophtalmologie, CHU Nantes, Nantes, France.
³ Service d'endocrinologie diabétologie nutrition, L'institut du thorax, CHU Nantes, Nantes, France. Electronic address: delphine.drui@chu-nantes.fr.

PMID: 35221112
DOI: 10.1016/j.revmed.2022.01.006

Abstract

Graves' orbitopathy is the most common extra-thyroid complication of Graves' disease and can be a potentially severe affection, therefore requiring multidisciplinary treatment support according to clinical activity and severity assessments. This review proposes to determine physiopathological mechanisms, epidemiology and therapeutic management of Graves' orbitopathy.

Publication types

Review

MeSH terms

Graves Disease*
Graves Ophthalmopathy* / diagnosis
Graves Ophthalmopathy* / epidemiology
Graves Ophthalmopathy* / therapy
Humans